BioCentury

12:58 AM GMT, Jun 24, 2008
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Dyax falls on DX-88 delay

Dyax (NASDAQ:DYAX) fell $0.41 (11%) to $3.35 on Monday after it said the planned closure of its clinical research provider, BattelleCRO

Read the full 211 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.